Managing clinical grant costs

Glass, 2007, Connecting the dots, Pharm Exec, 56 DiMasi, 2003, The price of innovation: new estimates of drug development costs, J Health Econ, 22, 151, 10.1016/S0167-6296(02)00126-1 Glass, 2008, The importance of medical innovation in an investigator's decision to take part in clinical trials, Drug Info J, 42, 537, 10.1177/009286150804200602 Glass, 1995, Higher payments to investigators don't speed study completion, Appl Clin Trials, 4 Glass, 2004, Do clinical grant payment practices in phase 3 clinical trials influence subsequent clinical investigator prescribing behavior?, Disease Manage, 7, 77, 10.1089/109350704322919014 Corrigan, 2005, Physician participation in clinical studies and subsequent prescribing of new drugs, Pharm Ther, 30, 60 Glass, 2006, Profiles of phase IV investigators and subsequent prescribing of the study drug, J Pharm Mark Manage, 17, 3, 10.1300/J058v17n03_02 Guldal, 2000, The influences of drug companies' advertising programs on physicians, Int J Health Serv, 3, 585, 10.2190/GYW9-XUMQ-M3K2-T31C Soumerai, 1998, Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial, JAMA, 279, 1358, 10.1001/jama.279.17.1358 Soumerai, 2000, Evaluating and improving physician prescribing, 483 Greer, 1988, The state of art versus the state of science: the diffusion of new medical technologies into practice, Int J Technol Assess Health Care, 4, 5, 10.1017/S0266462300003202 Naylor, 1998, Better care and better outcomes: the continuing challenge, JAMA, 279, 1392, 10.1001/jama.279.17.1392 H. Glass and J. DiFrancesco, Understanding site performance differences in multinational phase III clinical trials. Int J Pharm Med 21:(4): 279–286. University of the Sciences in Philadelphia and TTC's Investigator Site Survey: http://www.ttc-llc.com/Surveys/Profiles_of_Clinical_Invs_Questionnaire.pdf. July 2007. University of the Sciences in Philadelphia and TTC's Investigator Site Survey Result: http://www.ttc-llc.com/Surveys/Profiles_of_Clinical_Invs_Results.pdf. July 2007. Glass, 2007, The demographic, practice, and prescribing characteristics of US clinical investigators, Drug Info J, 41, 645, 10.1177/009286150704100511 Glass, 2006, Clinical grants under the microscope: what is a fair market value?, Good Clin Pract J, 23